Giving Full Measure to Countermeasures Addressing Problems in the DoD Program to Develop Medical Countermeasures Against Biological Warfare Agents (2004) / Chapter Skim
Currently Skimming:
Appendix D: Biographical Sketches
Appendix D: Biographical Sketches
Pages 131-140
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 131... ...
Center for Biologics Evaluation and Research External Peer Review Committee, the FDA Expert Panel on Individual Bioequivalence, and the FIP Board of Pharmaceutical Sciences and as a member of the FDA Science Board and the Board of Directors of the American Foundation for Pharmaceutical Education. An elected member of the Institute of Medicine (IOM)
|
From page 132... ...
Army Medical Research and Materiel Command he had oversight of the development, manufacture, and testing of vaccines and immune globulins, responsibility for more than 50 active Investigational New Drug applications with the FDA, and management of resources and activities that contributed to licensure of four vaccines. As a microbiologist and assistant chief of the Department of Virus Diseases, Walter Reed Army Institute of Research, he worked on teams studying dengue fever virus infections and the immune response, markers for live attenuated vaccine candidates, and characterization of reagents for diagnostic tests.
|
From page 133... ...
He also serves as a director of the biotechnology companies Vical, Elusys Therapeutics, Advancis Pharmaceutical Corporation, Iomai, and VaxInnate and the nonprofit organizations International AIDS Vaccine Initiative and Aeras Global TB Vaccine Foundation.
|
From page 134... ...
in 2001, four Senior Executive Service presidential rank awards, Distinguished Service Awards from the Secretaries of the Interior and Health and Human Services, and an exemplary service award from the Surgeon General. Dennis L
|
From page 135... ...
Kennedy School of Government, Harvard University, where he conducts research on public sector operations management with a focus on organizational design and change. He is the former Office of Federal Procurement Policy administrator in the Office of Management and Budget, where he was involved in the Federal Acquisition Streamlining Act of 1994 and the Federal Acquisition Reform Act of 1995.
|
From page 136... ...
Paul Parkman, M.D., retired as director of the Center for Biologics Evaluation and Research of the FDA in 1990, after 30 years of federal service (18 at FDA) in infectious disease research and biological product regulation.
|
From page 137... ...
Dr. Weigler is a member of several professional veterinary medical organizations and is on the editorial board for the scientific journal Comparative Medicine.
|
From page 138... ...
Gerrity was executive director of the Georgetown School of Medicine Chronic Pain and Fatigue Research Center, which focuses on a multidisciplinary approach to understanding the underlying mechanisms of chronic multisymptom illness. He has also served as special assistant chief research and development officer (19971999)
|
From page 139... ...
He currently directs a research group using antibody gene diversity libraries and display technologies to dissect the molecular basis of infectious diseases and cancer and to develop novel antibody-based therapeutic approaches for these diseases. In the field of oncology, his research has elucidated the impact of antibody biophysical properties on tumor targeting, and his laboratory has generated a novel antibody-based drug that is being commercialized for breast cancer therapy.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.